Previous 10 | Next 10 |
LAVAL, QC / ACCESSWIRE / December 18, 2023 / Bausch Health, Canada, part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), ("Bausch Health" or the "Company") today announced that DUOBRII™ (0.01% w/w halobetasol propionate and 0.045% w/w tazarotene), the company's novel topical prescrip...
2023-12-10 22:56:31 ET Summary Carl Icahn's 13F filing decreased from 15 to 14 holdings this quarter. The top five holdings in the filing are Icahn Enterprises, CVR Energy, Occidental Petroleum warrants, Southwest Gas Holdings, and FirstEnergy. Icahn disposed of his stake in X...
BRIDGEWATER, NJ / ACCESSWIRE / December 5, 2023 / Salix Pharmaceuticals, the gastroenterology division of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), The U.S. Pain Foundation (USPF), and The International Foundation for Gastrointestinal Disorders (IFFGD) today announced they are joining fo...
2023-11-30 05:33:24 ET Summary Bausch Health has a solid business model with steady revenue generation and strong operating income margins - but debt & litigation are crippling the business. The company's heavy debt of >$20bn, and pending litigation around lead product Xifa...
2023-11-24 22:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Lack of OHE-specific diagnostic code in hospitals may increase risk of additional cost, length of hospitalization and additional burdens for patients compared to those with a previous primary OHE diagnosis LAVAL, QC / ACCESSWIRE / November 10, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(T...
Company Introduces Multimedia Resources to Bring Awareness of SAD LAVAL, QC / ACCESSWIRE / November 8, 2023 / As daylight saving time concluded for much of the US on November 5, and as the seasons change and the days grow shorter, many people may find themselves grappling with the onset sym...
2023-11-02 12:51:00 ET Canadian specialty pharmaceutical firm Bausch Health ( NYSE: BHC ) on Thursday said it swung to a quarterly loss from a profit a year ago, primarily due to an increase in goodwill impairments and higher expenses. U.S.-listed shares of the company opened lo...
2023-11-02 10:12:06 ET Bausch Health Companies Inc. (BHC) Q3 2023 Earnings Conference Call November 2, 2023 8:00 AM ET Company Participants Lisa Wilson - Investor Relations Thomas Appio - Chief Executive Officer John Barresi - Interim Chief Financial Officer ...
2023-11-02 08:36:46 ET More on Bausch Health Companies Bausch Health Companies Inc. 2023 Q3 - Results - Earnings Call Presentation Bausch Health's Debt Dilemma: Strategic Decisions And Financial Metrics Bausch Health Companies Q3 2023 Earnings Preview Bausch ...
News, Short Squeeze, Breakout and More Instantly...
Bausch Health Companies Inc. Company Name:
BHC Stock Symbol:
NYSE Market:
LAVAL, QC / ACCESSWIRE / May 17, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today announced that they will be presenting data from its Phase 2 trial evaluating Amiselimod as treatment for active ulcerative colitis (UC). ...
LAVAL, QC / ACCESSWIRE / May 15, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the results of its 2024 annual meeting of shareholders. Annual Meeting Results The 10 directors nominated at the Company's 2024 annual meeting of shareholders held on May 14, 2024, were e...
LAVAL, QC / ACCESSWIRE / May 14, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology business Salix Pharmaceuticals, today announced certain updates related to its litigation with Norwich Pharmaceuticals, Inc. With respect to the April 11, 2024, decision of the US C...